Theriva Biologics Stock Price History
| TOVX Stock | USD 1.17 0.02 1.68% |
Below is the normalized historical share price chart for Theriva Biologics extending back to January 14, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Theriva Biologics stands at 1.17, as last reported on the 20th of March, with the highest price reaching 1.19 and the lowest price hitting 1.10 during the day.
If you're considering investing in Theriva Stock, it is important to understand the factors that can impact its price. Theriva Biologics appears to be somewhat reliable, given 3 months investment horizon. Theriva Biologics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0466, which indicates the firm had a 0.0466 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Theriva Biologics, which you can use to evaluate the volatility of the company. Please review Theriva Biologics' Coefficient Of Variation of 4020.45, semi deviation of 6.55, and Risk Adjusted Performance of 0.0309 to confirm if our risk estimates are consistent with your expectations.
At this time, Theriva Biologics' Other Stockholder Equity is fairly stable compared to the past year. Sale Purchase Of Stock is expected to grow at the current pace this year, whereas Total Stockholder Equity is likely to drop slightly above 11.4 M in 2025. . Price To Sales Ratio is likely to drop to 241.35 in 2025. Price Earnings Ratio is likely to drop to -0.1 in 2025. Theriva Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of December 2006 | 200 Day MA 3.0567 | 50 Day MA 1.431 | Beta 1.159 |
Theriva |
Sharpe Ratio = 0.0466
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TOVX | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.03 actual daily | 80 80% of assets are less volatile |
Expected Return
| 0.42 actual daily | 8 92% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Theriva Biologics is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Theriva Biologics by adding it to a well-diversified portfolio.
Theriva Biologics Stock Price History Chart
There are several ways to analyze Theriva Stock price data. The simplest method is using a basic Theriva candlestick price chart, which shows Theriva Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 14, 2025 | 1.91 |
| Lowest Price | March 13, 2025 | 1.11 |
Theriva Biologics March 20, 2025 Stock Price Synopsis
Various analyses of Theriva Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Theriva Stock. It can be used to describe the percentage change in the price of Theriva Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Theriva Stock.| Theriva Biologics Price Rate Of Daily Change | 0.98 | |
| Theriva Biologics Price Action Indicator | 0.01 | |
| Theriva Biologics Price Daily Balance Of Power | (0.22) | |
| Theriva Biologics Accumulation Distribution | 1,365 |
Theriva Biologics March 20, 2025 Stock Price Analysis
Theriva Stock Price History Data
The price series of Theriva Biologics for the period between Fri, Dec 20, 2024 and Thu, Mar 20, 2025 has a statistical range of 0.8 with a coefficient of variation of 12.59. The price distribution for the period has arithmetic mean of 1.41. The median price for the last 90 days is 1.42. The company completed stock split (1:25) on 26th of August 2024. Theriva Biologics had dividends distributed to its stock-holders on 2018-08-13.| Open | High | Low | Close | Volume | ||
| 03/19/2025 | 1.19 | 1.19 | 1.10 | 1.17 | 18,052 | |
| 03/18/2025 | 1.19 | 1.20 | 1.15 | 1.19 | 13,600 | |
| 03/17/2025 | 1.14 | 1.20 | 1.14 | 1.19 | 25,275 | |
| 03/14/2025 | 1.11 | 1.20 | 1.07 | 1.15 | 38,411 | |
| 03/13/2025 | 1.34 | 1.36 | 1.03 | 1.11 | 95,382 | |
| 03/12/2025 | 1.31 | 1.37 | 1.31 | 1.34 | 4,652 | |
| 03/11/2025 | 1.32 | 1.34 | 1.26 | 1.31 | 12,154 | |
| 03/10/2025 | 1.39 | 1.39 | 1.29 | 1.29 | 22,522 | |
| 03/07/2025 | 1.37 | 1.44 | 1.30 | 1.35 | 38,165 | |
| 03/06/2025 | 1.37 | 1.41 | 1.36 | 1.41 | 14,385 | |
| 03/05/2025 | 1.31 | 1.36 | 1.31 | 1.35 | 10,852 | |
| 03/04/2025 | 1.34 | 1.34 | 1.28 | 1.30 | 33,027 | |
| 03/03/2025 | 1.44 | 1.50 | 1.33 | 1.33 | 27,153 | |
| 02/28/2025 | 1.40 | 1.50 | 1.36 | 1.44 | 35,264 | |
| 02/27/2025 | 1.39 | 1.41 | 1.36 | 1.40 | 21,800 | |
| 02/26/2025 | 1.43 | 1.43 | 1.36 | 1.41 | 34,796 | |
| 02/25/2025 | 1.47 | 1.52 | 1.42 | 1.42 | 38,407 | |
| 02/24/2025 | 1.53 | 1.60 | 1.48 | 1.52 | 22,567 | |
| 02/21/2025 | 1.58 | 1.59 | 1.53 | 1.55 | 23,915 | |
| 02/20/2025 | 1.65 | 1.68 | 1.58 | 1.61 | 28,600 | |
| 02/19/2025 | 1.57 | 1.75 | 1.55 | 1.63 | 68,924 | |
| 02/18/2025 | 1.69 | 1.70 | 1.54 | 1.57 | 52,114 | |
| 02/14/2025 | 1.71 | 1.72 | 1.67 | 1.71 | 59,675 | |
| 02/13/2025 | 1.53 | 1.75 | 1.53 | 1.72 | 253,500 | |
| 02/12/2025 | 1.45 | 1.53 | 1.44 | 1.53 | 45,082 | |
| 02/11/2025 | 1.43 | 1.53 | 1.40 | 1.43 | 81,293 | |
| 02/10/2025 | 1.46 | 1.46 | 1.41 | 1.43 | 43,450 | |
| 02/07/2025 | 1.50 | 1.50 | 1.42 | 1.42 | 45,186 | |
| 02/06/2025 | 1.49 | 1.52 | 1.45 | 1.48 | 170,530 | |
| 02/05/2025 | 1.40 | 1.49 | 1.35 | 1.43 | 196,900 | |
| 02/04/2025 | 1.19 | 1.54 | 1.17 | 1.41 | 872,000 | |
| 02/03/2025 | 1.26 | 1.26 | 1.15 | 1.20 | 118,600 | |
| 01/31/2025 | 1.28 | 1.30 | 1.24 | 1.27 | 88,000 | |
| 01/30/2025 | 1.28 | 1.29 | 1.24 | 1.28 | 83,500 | |
| 01/29/2025 | 1.27 | 1.28 | 1.24 | 1.27 | 58,300 | |
| 01/28/2025 | 1.35 | 1.38 | 1.25 | 1.29 | 73,216 | |
| 01/27/2025 | 1.44 | 1.44 | 1.34 | 1.34 | 83,305 | |
| 01/24/2025 | 1.40 | 1.47 | 1.38 | 1.46 | 258,100 | |
| 01/23/2025 | 1.43 | 1.44 | 1.37 | 1.37 | 66,600 | |
| 01/22/2025 | 1.52 | 1.54 | 1.42 | 1.44 | 51,100 | |
| 01/21/2025 | 1.50 | 1.54 | 1.48 | 1.51 | 47,598 | |
| 01/17/2025 | 1.43 | 1.50 | 1.40 | 1.48 | 96,600 | |
| 01/16/2025 | 1.52 | 1.54 | 1.42 | 1.43 | 105,400 | |
| 01/15/2025 | 1.62 | 1.64 | 1.50 | 1.51 | 272,600 | |
| 01/14/2025 | 1.51 | 2.03 | 1.45 | 1.91 | 3,037,200 | |
| 01/13/2025 | 1.47 | 1.50 | 1.42 | 1.50 | 28,900 | |
| 01/10/2025 | 1.44 | 1.52 | 1.43 | 1.45 | 38,300 | |
| 01/08/2025 | 1.62 | 1.62 | 1.43 | 1.47 | 120,900 | |
| 01/07/2025 | 1.70 | 1.72 | 1.62 | 1.62 | 116,400 | |
| 01/06/2025 | 1.60 | 1.79 | 1.60 | 1.73 | 176,300 | |
| 01/03/2025 | 1.66 | 1.72 | 1.58 | 1.59 | 116,400 | |
| 01/02/2025 | 1.73 | 1.75 | 1.62 | 1.65 | 163,500 | |
| 12/31/2024 | 1.54 | 1.77 | 1.50 | 1.75 | 519,476 | |
| 12/30/2024 | 1.48 | 1.53 | 1.44 | 1.50 | 165,437 | |
| 12/27/2024 | 1.50 | 1.59 | 1.41 | 1.47 | 296,200 | |
| 12/26/2024 | 1.40 | 1.64 | 1.40 | 1.58 | 893,200 | |
| 12/24/2024 | 1.53 | 2.08 | 1.47 | 1.76 | 6,858,100 | |
| 12/23/2024 | 1.15 | 1.33 | 1.15 | 1.30 | 10,382,000 | |
| 12/20/2024 | 1.16 | 1.19 | 1.14 | 1.14 | 48,500 | |
| 12/19/2024 | 1.19 | 1.19 | 1.14 | 1.15 | 43,400 | |
| 12/18/2024 | 1.15 | 1.21 | 1.15 | 1.17 | 35,900 |
About Theriva Biologics Stock history
Theriva Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Theriva is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Theriva Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Theriva Biologics stock prices may prove useful in developing a viable investing in Theriva Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.3 M | 1.1 M | |
| Net Loss | -22.6 M | -23.8 M |
Theriva Biologics Quarterly Net Working Capital |
|
Theriva Biologics Stock Technical Analysis
Theriva Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
| All Next | Launch Module |
Theriva Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Theriva Biologics' price direction in advance. Along with the technical and fundamental analysis of Theriva Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Theriva to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0309 | |||
| Jensen Alpha | 0.3201 | |||
| Total Risk Alpha | 1.16 | |||
| Sortino Ratio | 0.0449 | |||
| Treynor Ratio | 0.1749 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Theriva Stock Analysis
When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.